甲状腺機能検査の市場規模・シェア・成長分析 (種類別、エンドユーザー別、地域別)：産業予測 (2024～2031年)

世界の甲状腺機能検査の市場規模は、2022年に11億米ドルと評価され、2023年の12億米ドルから2031年には24億5,000万米ドルに成長し、予測期間 (2024-2031年) のCAGRは9.3%で成長する見通しです。

甲状腺機能検査市場は、バセドウ病や橋本甲状腺炎などの甲状腺疾患の有病率の増加により、大きな成長が見込まれています。高齢者人口の増加と甲状腺の健康に対する意識の高まりにより、これらの血液検査の需要は急増すると予想されます。病院や研究所を含むいy労部門は、TSH、T4、T3、遊離T4のような重要なホルモンレベルを測定するこれらの検査に大きく依存しています。座りがちなライフスタイル、過度のアルコール摂取、自己免疫疾患や糖尿病の増加といった要因が、市場の拡大をさらに後押ししています。さらに、革新的な検出方法の開発を目指した主要業界企業間の戦略的提携が、成長を後押しします。全体として、米国の甲状腺機能検査市場は今後数年間、堅調なCAGRを維持すると予測されます。

目次

イントロダクション

• 分析目的
• 市場範囲
• 定義

分析手法

• 情報調達
• 二次・一次データの手法
• 市場規模予測
• 市場の想定と制約

エグゼクティブサマリー

• 市場の概要と展望
• 需給動向の分析
• セグメント別の機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

市場の主な考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場魅力度指数 (2023年)
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

世界の甲状腺機能検査の市場規模・CAGR：種類別 (2024～2031年)

• 市場概要
• TSH検査
• T4検査
• T3検査
• その他の検査

世界の甲状腺機能検査の市場規模・CAGR：エンドユーザー別 (2024～2031年)

• 市場概要
• 病院
• 診断検査室
• 検査室・研究所
• その他のエンドユーザー

世界の甲状腺機能検査の市場規模・CAGR (2024～2031年)

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング (2023年)
• 主要企業が採用した戦略
• 市場の近年の動向
• 主要企業の市場シェア (2023年)
• 主要企業のプロファイル
  • 企業概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較 (2021～2023年)

主要企業のプロファイル

• Thermo Fisher Scientific (米国)
• Abbott Laboratories (米国)
• Roche Diagnostics (スイス)
• Danaher Corporation (米国)
• DiaSorin (イタリア)
• Siemens Healthineers (ドイツ)
• Merck KGaA (ドイツ)
• Bio-Rad Laboratories (米国)
• Ortho Clinical Diagnostics (米国)
• Beckman Coulter (米国)
• F. Hoffmann-La Roche Ltd. (スイス)
• QuidelOrtho (米国)
• Inova Diagnostics (米国)
• Sekisui Diagnostics (米国)
• Trinity Biotech (アイルランド)
• ARUP Laboratories (米国)
• Quest Diagnostics (米国)
• Laboratory Corporation of America Holdings (米国)
• Eurofins Scientific (ルクセンブルク)
• MSD (Merck & Co.) (米国)

結論と推奨事項

Global Thyroid Function Test Market size was valued at USD 1.1 billion in 2022 and is poised to grow from USD 1.2 billion in 2023 to USD 2.45 billion by 2031, growing at a CAGR of 9.3% during the forecast period (2024-2031).

The Thyroid Function Test market is poised for significant growth, driven by an increasing prevalence of thyroid disorders such as Graves' disease and Hashimoto's thyroiditis. With a rising geriatric population and heightened awareness of thyroid health, demand for these blood tests is anticipated to surge. Healthcare sectors, including hospitals and research laboratories, rely heavily on these tests, which measure vital hormone levels like TSH, T4, T3, and free T4. Contributing factors such as sedentary lifestyles, excessive alcohol consumption, and the rise of autoimmune disorders and diabetes further underpin market expansion. Additionally, strategic collaborations among key industry players aimed at developing innovative detection methods will bolster growth. Overall, the U.S. Thyroid Function Test market is projected to sustain a robust CAGR in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Thyroid Function Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Thyroid Function Test Market Segmental Analysis

Global Thyroid Function Test Market is segmented by type, end user and region. Based on type, the market is segmented into TSH tests, t4 tests, t3 tests and other tests. Based on end user, the market is segmented into hospitals, diagnostic laboratories, research laboratories & institutes and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Thyroid Function Test Market

The global market for thyroid function tests is anticipated to experience significant growth due to the rising incidence of thyroid cancers coupled with the pressing demand for affordable diagnostic solutions. As more individuals seek effective screening methods for thyroid disorders, the market is further propelled by increased government funding aimed at enhancing healthcare infrastructure in both developed and emerging countries. Additionally, the swift evolution of lifestyle factors contributing to thyroid health emphasizes the critical need for such tests. Collectively, these factors are set to stimulate advancements and expansions within the thyroid function test market throughout the forecast period.

Restraints in the Global Thyroid Function Test Market

The Global Thyroid Function Test (GTFT) is a comprehensive assessment that evaluates the hormonal activity and regulatory mechanisms of the thyroid gland through a singular, integrative approach. Its primary restraint lies in the potential for false positives or negatives, influenced by individual variations in thyroid hormone metabolism, concurrent illnesses, or medications that may interfere with thyroid function. Additionally, GTFT may not specifically identify the nuances of certain thyroid disorders, leading to misinterpretation of results. Consequently, it should be interpreted in conjunction with clinical evaluations and additional diagnostic tests to ensure accurate assessment and effective management of thyroid-related conditions.

Market Trends of the Global Thyroid Function Test Market

The global thyroid function test market is witnessing a significant trend towards point-of-care testing, driven by the demand for convenience and faster results. This shift allows for immediate diagnosis and ongoing monitoring of thyroid disorders, enhancing patient management and treatment outcomes. By enabling tests to be conducted outside traditional laboratory settings, point-of-care testing reduces the waiting period for results, thus improving accessibility for patients. As healthcare providers prioritize efficient diagnostic solutions, the adoption of portable, user-friendly devices is expected to rise, further propelling market growth. This trend reflects a broader movement towards personalized medicine and streamlined healthcare delivery.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Thyroid Function Test Market Size by Type & CAGR (2024-2031)

• Market Overview
• TSH Tests
• T4 Tests
• T3 Tests
• Other Tests

Global Thyroid Function Test Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Research Laboratories & Institutes
• Other End Users

Global Thyroid Function Test Market Size & CAGR (2024-2031)

• North America (Type, End User)
  • US
  • Canada
• Europe (Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inova Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARUP Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD (Merck & Co.) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations